TCEAL7 and neoplasm: According to a study by Lopez‐Serra and colleagues, MBDs show a high affinity for the in vivo binding of TSGs with hypermethylated promoter CpG islands, and their occupancy profiles vary depending on the gene and type of tumor,186, 187 methylation inactivated a new candidate TSG TCEAL7 in ovarian cancer.